US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
HL

HLN.L

Stock Haleon plc
$333.80

London Stock Exchange · Healthcare · GB

Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.52%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Haleon plc (HLN.L) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$420.24
+25.9% · 17 analysts
Institutional own.
59.4%
of shares
COMPLIANT
Sharia compliance
0.52%
Non-permissible income — HTR, from filings (2025-12-31)
$420.24
Price target (+25.9%) · 17 analysts
59.4%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. HLN.L files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 26.23% 30.00% Pass
Interest-bearing investments 3.79% 30.00% Pass
Non-permissible income 0.52% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 26.71% 33.00% Pass
Interest-bearing investments 3.86% 33.00% Pass
Non-liquid assets 91.11% at least 20.00% Pass
Non-permissible income 0.52% 5.00% Pass

MSCI Pass

RatioValueThresholdResult
Interest-bearing debt 26.71% 33.33% Pass
Cash + interest-bearing securities 3.86% 33.33% Pass
Accounts receivable 8.89% 33.33% Pass
Non-permissible income 0.52% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 26.71% 33.33% Pass
Cash + interest-bearing securities 3.86% 33.33% Pass
Accounts receivable 8.89% 50.00% Pass
Non-permissible income 0.52% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 23.33% 33.00% Pass
Cash + interest-bearing securities 3.37% 33.00% Pass
Accounts receivable 4.39% 33.00% Pass
Non-permissible income 0.52% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 23.98% 33.00% Pass
Cash + interest-bearing securities 3.47% 49.00% Pass
Accounts receivable 4.52% 49.00% Pass
Non-permissible income 0.52% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 23.98% 33.33% Pass
Cash + interest-bearing securities 3.47% 33.33% Pass
Accounts receivable 7.98% 49.00% Pass
Non-permissible income 0.52% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

410.82388.33365.85343.36320.882025-09-122026-03-122026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
327.00
S2
330.00
S1
333.10
PIVOT
336.10
R1
339.20
R2
342.20
R3
345.30

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
348.67 383.33
±4.73% from 366.00, made 2026-09-03 · resolves 2026-09-10
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22593 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsBUY
4 buy · 0 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)29.40BUY
Stochastic %K (14)1.92BUY
CCI (20)-144.83BUY
Williams %R (14)-98.08BUY
MACD (12,26,9)-3.69SELL
ROC (10)-9.66SELL
Momentum (10)-35.70SELL
EMA (10)346.05SELL
SMA (10)349.99SELL
EMA (20)352.88SELL
SMA (20)356.22SELL
EMA (30)355.45SELL
SMA (30)358.72SELL
EMA (50)356.52SELL
SMA (50)361.85SELL
EMA (100)356.73SELL
SMA (100)350.27SELL
EMA (200)360.27SELL
SMA (200)363.09SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Haleon plc

Healthcare · Drug Manufacturers - Specialty & Generic

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

haleon.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio 29.3% (< 30%)
Investments ratio 4.5% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio 26.4% (< 33%)
Investments ratio 4.1% (< 33%)
Nonliquid assets ratio 89.6% (< 20%)
Non permissible income ratio no data
Net liquid assets -$1.6B (mkt cap $29.4B)

Based on the filing period ending 2025-12-31, figures in GBP.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.